Published May 2002
| Version v1
Journal article
Evaluation of clinical value of combined tumor markers detection in diagnosis of lung cancer
- 1. Fudan Univ., Shanghai (China). Huashan Hospital
Description
To evaluate clinical value of single or combined tumor marker detection CY21-1, CEA, CA15-3 and SCC in the diagnosis of lung cancer. There was retrospective analysis of 87 lung cancer inpatients, all of them was confirmed by pathology. Results showed: (1) Sensitivity of CY21-1, CEA, CA15-3 and SCC by single detection in diagnosing lung cancer was 59.8%, 39.1%, 44.8%, 18.4%, respectively. (2) Sensitivity of group I (CY21-1 + CEA) was 78.2%; sensitivity of group II (CY21-1 + CEA + CA15-3) was 88.5%; sensitivity of group III (CY21-1 + CEA + CA15-3 + SCC) was the same as group II. In the diagnosis of lung cancer, the combined detection with CY21-1, CEA, CA15-3 was an ideal selective combination
Additional details
Publishing Information
- Journal Title
- Nuclear Techniques
- Journal Volume
- 25
- Journal Issue
- 5
- Journal Page Range
- p. 380-382
- ISSN
- 0253-3219
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 34043934
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Numerical Data
- Descriptors DEI
- BIOLOGICAL MARKERS; BLOOD SERUM; CARCINOMAS; DIAGNOSTIC TECHNIQUES; EXPERIMENTAL DATA; LUNGS; PATHOLOGICAL CHANGES; RADIOIMMUNODETECTION; SENSITIVITY
- Descriptors DEC
- BIOLOGICAL MATERIALS; BLOOD; BLOOD PLASMA; BODY; BODY FLUIDS; DATA; DIAGNOSTIC TECHNIQUES; DISEASES; INFORMATION; ISOTOPE APPLICATIONS; MATERIALS; NEOPLASMS; NUMERICAL DATA; ORGANS; RADIOASSAY; RESPIRATORY SYSTEM; TRACER TECHNIQUES